In a report released yesterday, Marie Thibault from BTIG maintained a Hold rating on Senseonics Holdings (SENS – Research Report). The company’s shares closed yesterday at $1.20.
Thibault covers the Healthcare sector, focusing on stocks such as Viewray, Atricure, and Edwards Lifesciences. According to TipRanks, Thibault has an average return of 4.0% and a 31.25% success rate on recommended stocks.
Currently, the analyst consensus on Senseonics Holdings is a Moderate Buy with an average price target of $3.00.
See Insiders’ Hot Stocks on TipRanks >>
SENS market cap is currently $577.2M and has a P/E ratio of 6.20.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Senseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.
